|
Index of reports
> Cases resulting in life threatening events (7)
Below is the selection of adverse event reports related to Diovan HCT (Valsartan / Hydrochlorothiazide) that includes cases resulting in life threatening events.
Adverse event in 59 year old female receiving Diovan HCT (Valsartan / Hydrochlorothiazide)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-15
Patient: 59 year old female, weighing 71.2 kg (156.6 pounds)
Adverse reactions / side effects: Blood Urea Increased, Pulmonary Artery Aneurysm, Liver Function Test Abnormal, Proteinuria, Sepsis, Blood Creatinine Increased, Renal Failure Acute, White Blood Cell Count Increased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Diovan HCT
Administration route: Oral
Indication: Hypertension
Ibuprofen
Dosage: 600 mg, tid
Administration route: Oral
Indication: Headache
End date: 2007-03-27
Other drugs received by patient: Crestor; Amitriptyline HCL; Fish OIL; Calcium with Vitamin D; Vitamin CAP
Adverse event in female receiving Diovan HCT (Valsartan / Hydrochlorothiazide)
Reported by a individual with unspecified qualification from United States on 2007-10-09
Patient: female
Adverse reactions / side effects: Embolism, Hypotension, Pulmonary Embolism, Oxygen Saturation Decreased
Adverse event resulted in: life threatening event
Suspect drug(s):
Diovan HCT
Dosage: 80 mg val 12.5 hct, qd
Administration route: Oral
Indication: Hypertension
Start date: 2006-12-08
End date: 2007-09-11
Premarin
Dosage: unk, unk
Adverse event in 67 year old female receiving Diovan HCT (Valsartan / Hydrochlorothiazide)
Reported by a physician from United States on 2007-10-05
Patient: 67 year old female, weighing 52.2 kg (114.8 pounds)
Adverse reactions / side effects: Hypotension
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Diovan HCT
Dosage: 160/25 qd, oral
Administration route: Oral
Indication: Hypertension
Tekturna
Dosage: 150 mg, qd, oral
Administration route: Oral
Indication: Hypertension
Start date: 2007-06-14
End date: 2007-06-27
Other drugs received by patient: Chantix; Aciphex; Crestor
Adverse event in 69 year old male receiving Diovan HCT (Valsartan / Hydrochlorothiazide)
Reported by a individual with unspecified qualification from United States on 2007-07-19
Patient: 69 year old male, weighing 88.4 kg (194.6 pounds)
Adverse reactions / side effects: Surgery, Renal Failure, Fatigue, Neoplasm Malignant, Pollakiuria, Renal Cell Carcinoma Stage Unspecified, Gait Disturbance, Hypertension, Lung Infiltration, Blood Creatinine Increased, Decreased Appetite, Metastases TO Lung
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Diovan HCT (Valsartan / Hydrochlorothiazide)
Other drugs received by patient: Indocin
Adverse event in female receiving Diovan HCT (Valsartan / Hydrochlorothiazide)
Reported by a consumer/non-health professional from United States on 2007-05-01
Patient: female, weighing 72.6 kg (159.7 pounds)
Adverse reactions / side effects: Food Aversion, Thinking Abnormal, Fear, Insomnia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Diovan HCT (Valsartan / Hydrochlorothiazide)
Adverse event in 40 year old female receiving Diovan HCT (Valsartan / Hydrochlorothiazide)
Reported by a consumer/non-health professional from Venezuela on 2007-03-15
Patient: 40 year old female
Adverse reactions / side effects: Fatigue, Renal Failure, Respiratory Disorder, Arterial Disorder, Hypotension, Abdominal Distension, Asthenia, Cardiac Disorder, Hypertensive Crisis
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Diovan HCT
Dosage: 160/25 mg
Indication: Hypertension
End date: 2006-10-01
Foradil
Adverse event in 73 year old male receiving Diovan HCT (Valsartan / Hydrochlorothiazide)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-01-23
Patient: 73 year old male
Adverse reactions / side effects: Jaundice, Stent Placement, Hepatic Enzyme Increased
Adverse event resulted in: life threatening event
Suspect drug(s):
Crestor
Administration route: Oral
End date: 2007-01-18
Diovan HCT
Dosage: 12.5/160
Imdur
Temazepam
Vistaril
Zestril
Administration route: Oral
End date: 2007-01-18
Other drugs received by patient: Acetaminophen; Codeine Phos.; Aspirin; Coreg; Furosemide; Humulin N; Humulin 70 / 30; Klor-CON; Plavix
|